Pharmathene Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Pharmathene Inc
TickerALT
CIK #0001326190
CUSIP02155H101
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Park Place, Suite 450, Annapolis, MD 21401
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Pharmathene Inc 2010-11-19 9.9 M Exemption: 506 · Minimum: $6,000 · Remaining: $12,663,113 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001326190] 10-K
[0001326190] 10-Q
[0001326190] 3
[0001326190] 4
[0001326190] 5
[0001326190] 8-K
[0001326190] SC 13D
[0001326190] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Altimmune Inc [2026-05-12] 0.0
Viking Global Investors LP Altimmune Inc [2026-05-01] 0.0
TCG Crossover GP II LLC Altimmune Inc [2026-05-01] 0.0
RA Capital Management LP Altimmune Inc [2026-05-01] 0.0
Deep Track Capital LP Altimmune Inc [2026-04-30] 0.0
Millennium Management LLC Altimmune Inc [2024-03-05] 5.4
Ameriprise Financial Inc Altimmune Inc [2024-02-14] 81947.79
BlackRock Inc Altimmune Inc [2024-01-26] 7.5
Janus Henderson Group PLC Altimmune Inc [2023-02-13] 7.8
Vanguard Group Inc Altimmune Inc [2023-02-09] 5.15
BlackRock Inc Altimmune Inc [2022-07-08] 2.2
Cormorant Asset Management LP Altimmune Inc [2022-07-07] 6.13
Tang Capital Partners LP Altimmune Inc [2022-03-24] 5.1
TIAA CREF Investment Management LLC Altimmune Inc [2022-02-11] 5.76
Teachers Advisors LLC Altimmune Inc [2022-02-11] 5.76
BlackRock Inc Altimmune Inc [2022-02-04] 7.4
Avidity Partners Management LP Altimmune Inc [2022-01-03] 7.0
State Street Corp Altimmune Inc [2021-09-10] 10.05
Sphera Funds Management Ltd Altimmune Inc [2021-08-31] 8.84
Venrock Healthcare Capital Partners II LP Altimmune Inc [2021-03-01] 0.99
Baker Bros Advisors LP Altimmune Inc [2021-02-16] 5.1
D E Shaw & Co LP Altimmune Inc [2020-10-05] 5.0
D E Shaw & Co LP Altimmune Inc [2020-09-24] 5.0
Venrock Healthcare Capital Partners II LP Altimmune Inc [2020-06-25] 20.8
Venrock Healthcare Capital Partners II LP Altimmune Inc [2020-06-01] 19.3
Velocity Pharmaceutical Holdings LLC Altimmune Inc [2020-02-14] 12.3
Intracoastal Capital LLC Altimmune Inc [2018-10-17] 7.6
CVI Investments Inc Altimmune Inc [2018-10-05] 0.9
Hudson Bay Capital Management LP Altimmune Inc [2018-02-02] 0.99
Truffle Capital SAS Altimmune Inc [2017-05-15] 10.1
Hodges Philip Altimmune Inc [2017-05-15] 8.54
OFCO Club V Altimmune Inc [2017-05-15] 7.5
Novartis BioVentures Ltd Altimmune Inc [2017-05-08] 11.1
Renaissance Technologies LLC Pharmathene Inc [2017-02-14] 5.02
JFL Capital Management LLC Pharmathene Inc [2016-10-19] 5.05
Prescott Group Capital Management LLC Pharmathene Inc [2014-04-02] 9.8
Prescott Group Capital Management LLC Pharmathene Inc [2013-09-26] 10.0
Theraclone Sciences Inc Pharmathene Inc [2013-08-12] 7.6
Form 3/4/5 Filer 2011 - 2026
Pharmathene Inc
Lawver Teri L
Sohn Catherine A
Jorkasky Diane
Pisano Wayne
Schafer Klaus
Hodges Philip
Gill John
Sayare Mitchel
Durso Jerome Benedict
Weaver Gregory L
Roberts M Scot
Garg Vipin K
Jordt Raymond M
Arbet-Engels Christophe
Harris Matthew Scott
Drutz David
Shutterly Andrew
Eisenstadt Richard I
Brown William Michael
Shah Nimish P
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
VHCP Management III LLC
Venrock Healthcare Capital Partners II LP
Koh Bong Y
Venrock Healthcare Capital Partners III LP
VHCP Co-Investment Holdings III LLC
Velocity Pharmaceutical Holdings LLC
Watson James F
Velocity Pharma Management LLC
Collier David J
Tasker Sybil
Novartis AG
Novartis BioVentures Ltd
Enright William
Truffle Capital SAS
Schaffer Derace L
Redmont VAXN Capital Holdings LLC
Czerepak Elizabeth
Redmont Venture Partners Inc
Paradigm Venture Partners LP
Runge Jeffrey W
St Peter Steven
Macneill Philip
Prescott Group Capital Management LLC
Frohlich Phil
Richman Eric I
Jones Jeffrey Michael
Chang Linda L
Markison Brian A
McCleary Joel
Cook Francesca M
Morges Wayne
Karp Jordan P
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Durso Jerome Benedict
Common Stock, par value $0.0001
2026-03-06 Buy 20,000 $3.54 70,800
Weaver Gregory L
Common Stock, par value $0.0001
2026-03-06 Buy 5,000 $3.54 17,700
Weaver Gregory L
Restricted Stock Units · derivative
2026-02-26 Grant 111,000 $0.00
Roberts M Scot
Stock Options (option to buy) · derivative
2026-02-26 Grant 222,670 $0.00
Weaver Gregory L
Stock Options (option to buy) · derivative
2026-02-26 Grant 259,000 $0.00
Roberts M Scot
Restricted Stock Units · derivative
2026-02-26 Grant 95,430 $0.00
Roberts M Scot
Restricted Stock Units · derivative
2026-02-02 Option exercise 7,775 $0.00
Roberts M Scot
Common Stock, par value $0.0001
2026-02-02 Option exercise 7,775 $0.00
Roberts M Scot
Common Stock, par value $0.0001
2026-02-02 Tax withheld 2,329 $5.55 12,926
Jordt Raymond M
Common Stock, par value $0.0001
2026-01-31 Grant 4,571 $3.07 14,033
Garg Vipin K
Common Stock, par value $0.0001
2026-01-31 Grant 6,926 $3.07 21,263
Roberts M Scot
Common Stock, par value $0.0001
2026-01-31 Grant 5,567 $3.07 17,091
Roberts M Scot
Common Stock, par value $0.0001
2026-01-30 Tax withheld 2,859 $5.60 16,010
Roberts M Scot
Common Stock, par value $0.0001
2026-01-30 Option exercise 9,275 $0.00
Garg Vipin K
Common Stock, par value $0.0001
2026-01-30 Tax withheld 11,632 $5.60 65,139
Roberts M Scot
Restricted Stock Units · derivative
2026-01-30 Option exercise 9,275 $0.00
Garg Vipin K
Restricted Stock Units · derivative
2026-01-30 Option exercise 26,775 $0.00
Garg Vipin K
Common Stock, par value $0.0001
2026-01-30 Option exercise 26,775 $0.00
Garg Vipin K
Common Stock, par value $0.0001
2026-01-27 Tax withheld 17,898 $6.18 110,610
Jordt Raymond M
Common Stock, par value $0.0001
2026-01-27 Tax withheld 4,229 $6.18 26,135
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 174 71,435,059
2025-12-31 186 60,481,881
2025-09-30 164 48,123,660
2025-06-30 188 46,545,585
2025-03-31 183 41,870,922
2024-12-31 186 43,755,681
2024-09-30 170 41,165,900
2024-06-30 175 44,173,336
2024-03-31 173 50,534,662
2023-12-31 145 36,828,457
2023-09-30 114 31,089,770
2023-06-30 120 35,781,959
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 518,198 518,198
Beirne Wealth Consulting Services LLC [2026-06-30] SOLE 0 421,858
Brown Wealth Management LLC [2026-06-30] SOLE 0 236,136
Summit Financial Wealth Advisors LLC [2026-06-30] SOLE 0 103,288
PVG Asset Management Corp [2026-06-30] SOLE 700 66,120
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 32,285
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 860 25,989
Activest Wealth Management [2026-06-30] SOLE 0 5,001
Farther Finance Advisors LLC [2026-06-30] SOLE 0 1,044
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 1,000 1,000
Elevation Wealth Partners LLC [2026-06-30] SOLE 0 286
True Wealth Design LLC [2026-06-30] SOLE 0 196
Gamma Investing LLC [2026-06-30] DFND 134 134
First Horizon Corp [2026-06-30] DFND 0 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com